Advertisement

Vogt-Koyanagi-Harada Syndrome (VKH Syndrome)

  • An-Guor Wang
Chapter

Abstract

A 62-year-old female presented with complaints of gradual blurring OU for 2 weeks. She had suffered a recent upper respiratory infection and treated it with unidentified herbal drugs. Her best-corrected vision was 6/30 in the right eye and 6/15 in the left eye. Intraocular pressure was normal. There was mild nuclear sclerosis in both lenses. The pupillary light reflex was mildly sluggish for both eyes. Fundoscopic examination showed swollen discs and serous detachments over the macula in both eyes (Fig. 14.1). A visual field test showed severe obscuration in the right eye and constriction in the left eye (Fig. 14.2). Multiple pinpoint leakages over the macular region were noted on fluorescein angiography (Fig. 14.3). A brain CT was negative for space-occupying lesions and did not indicate any signs of increased intracranial pressure. MR imaging showed thickened retino-choroidal layers in both eyes (Fig. 14.4). A lumbar puncture showed normal intracranial pressure and increased lymphocytes in the cerebrospinal fluid. The patient received methylprednisolone pulse therapy for 3 days and was then discharged with oral steroid medications. Her vision recovered to 6/7.5 in the right eye and 6/6.7 in the left eye. Her fundus had multiple patches of depigmentation 5 years later (Fig. 14.5).

References

  1. 1.
    Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 1996;80(11):1002–8.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Sugita S, Sagawa K, Mochizuki M, et al. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int Immunol. 1996;8(5):799–803.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Rao NA, Moorthy RS, Inomata H. Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin. 1995;35(2):69–86.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Sukavatcharin S, Tsai JH, Rao NA. Vogt-Koyanagi-Harada disease in Hispanic patients. Int Ophthalmol. 2007;27(2–3):143–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Kitamura M, Takami K, Kitaichi N, et al. Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada’s disease. Am J Ophthalmol. 2005;139(6):1080–5.CrossRefPubMedGoogle Scholar
  6. 6.
    O’Keefe GA, Rao NA. Vogt-Koyanagi-Harada disease. Surv Ophthalmol. 2017;62(1):1–25.CrossRefPubMedGoogle Scholar
  7. 7.
    Goto H, Rao NA. Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin. 1990;30:279–85.CrossRefPubMedGoogle Scholar
  8. 8.
    Gass JDM. Harada’s disease. Stereoscopic atlas of macular diseases. Diagnosis and treatment. St. Louis: C. V. Mosby Co.; 1987. p. 150–3.Google Scholar
  9. 9.
    Arellanes-García L, Hernández-Barrios M, Fromow-Guerra J, et al. Fluorescein fundus angiographic findings in Vogt-Koyanagi-Harada syndrome. Int Ophthalmol. 2007;27(2–3):155–61.CrossRefPubMedGoogle Scholar
  10. 10.
    Beniz J, Forster DJ, Lean JS, et al. Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina. 1991;11(3):275–80.CrossRefPubMedGoogle Scholar
  11. 11.
    Fardeau C, Tran TH, Gharbi B, et al. Retinal fluorescein and indocyanine green angiography and optical coherence tomography in successive stages of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27(2–3):163–72.CrossRefPubMedGoogle Scholar
  12. 12.
    Maruyama Y, Kishi S. Tomographic features of serous retinal detachment in Vogt-Koyanagi-Harada syndrome. Ophthalmic Surg Lasers Imaging. 2004;35(3):239–42.PubMedGoogle Scholar
  13. 13.
    Nakai K, Gomi F, Ikuno Y, et al. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250(7):1089–95.CrossRefPubMedGoogle Scholar
  14. 14.
    Miyanaga M, Kawaguchi T, Shimizu K, et al. Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27(2–3):183–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Dolz-Marco R, Gallego-Pinazo R, Díaz-Llopis M. Rituximab in refractory Vogt-Koyanagi-Harada disease. J Ophthalmic Inflamm Infect. 2011;1(4):177–80.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • An-Guor Wang
    • 1
  1. 1.Department of OphthalmologyTaipei Veterans General Hospital, National Yang-Ming University School of Medicine, Yun-San Ophthalmology Education Research FoundationTaipeiTaiwan

Personalised recommendations